ImmunoGen (IMGN) Q3 Loss Narrower Than Expected, Revenues Lag

Published on November 1, 2021

ImmunoGen (IMGN) reports narrower-than-expected loss but misses revenue estimates. The company lowers its operating expense guidance for 2021.

Continue reading on website
Other news

McDonald's Is Making Its Famous McRib Sandwich Into an NFT

November 1, 2021
The cult-favorite menu item returns this month, in more than one form.

What's in the Cards for MercadoLibre's (MELI) Q3 Earnings?

November 1, 2021
MercadoLibre's (MELI) third-quarter performance is expected to have benefited from its fintech and logistics offerings amid the pandemic.